|Page (1) of 1 - 04/12/12||email article||print page|
Threshold Pharmaceuticals (NASDAQ:THLD) earned a $20 million milestone payment from Merck KGaA (PINK:MKGAF).The payment was related to performance of its TH-302 pancreatic cancer treatment candidate in a Phase 2 trial.
|Threshold Pharmaceuticals Receives $20 Million Milestone Payment|
Source:GrabNetworks (c). All Rights Reserved